RxDoctor Payments Data

Homan Mostafavi, DO

Otolaryngology/Facial Plastic Surgery · Chandler, AZNPI 1770679797

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,483 of the $7,028 with a category attached, or 63.8%. 13 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 59.3% of the total. Reporting peaked in 2021 at $4,512 and has fallen 93.0% since, to $315 in 2025.

$7,028in general payments, 2019–2025

Across 26 payments — averaging $270.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$4K
  • ZOLL Respicardia, Inc.$2K
  • Aerin Medical Inc.$294
  • Watermark Medical, Inc.$290
  • Intersect ENT, Inc.$143
  • Itamar Medical Inc$125
  • plus $207 from 7 others

What the payments were for

  • Consulting fees$87512%
  • Travel & lodging$1,67024%
  • Food & beverage$4,48364%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Arizonato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$145,782
Medicare patients
311
Services billed
1,972

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl12$538
Montelukast Sodium11$114

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Chandler

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →